A new study published in the Journal of Psychopharmacology suggests that people who had consumed classic psychedelics before experiencing an extreme traumatic event reported lower levels of anxiety and post-traumatic …
PsychopharmacologyPsychedelics may buffer against PTSD, finds new study of survivors of Nova music festival massacre
NeuroscienceNeuroscientists just discovered a fascinating fact about the grooves in your brain
A new study published in The Journal of Neuroscience offers insight into how small grooves in the brain’s surface — known as tertiary sulci — might help explain individual differences …
PsychopharmacologyAyahuasca entity encounters linked to lasting religious belief changes, especially in men
An online survey of ayahuasca users found that non-religious individuals tend to become more religious after experiencing entity encounters while under the influence of the substance. Although men were less …
NeuroscienceStudy links anorexia nervosa to elevated opioid receptor levels in brain’s reward centers
A new neuroimaging study published in Molecular Psychiatry provides evidence that anorexia nervosa is associated with altered activity in the brain’s opioid system. Women with anorexia had higher levels of …
PsychopharmacologyPsilocybin therapy shows similar benefits for patients with and without recent antidepressant use
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights. A new study published in The Canadian Journal of Psychiatry suggests that individuals …
PsychopharmacologyPsychedelic experiences can both cause and resolve spiritual struggles, study suggests
A new study published in Psychology of Religion and Spirituality explores how psychedelic experiences relate to people’s spiritual struggles. Some participants associated their experiences with a sense of spiritual growth, …
PsychopharmacologyCommon sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model
A recent study published in Nature Neuroscience provides evidence that lemborexant, a medication used to treat insomnia, can reduce brain damage linked to Alzheimer’s disease in a mouse model. The …